Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus
- PMID: 12875772
- DOI: 10.1016/s0735-1097(03)00625-9
Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus
Abstract
Objectives: This study evaluated myocardial function in relation to high-energy phosphate (HEP) metabolism in asymptomatic patients with uncomplicated type 2 diabetes mellitus using magnetic resonance (MR) techniques.
Background: Myocardial dysfunction may occur in patients with type 2 diabetes mellitus in the absence of coronary artery disease or left ventricular (LV) hypertrophy. The mechanisms underlying this diabetic cardiomyopathy are largely unknown, but may involve altered myocardial energy metabolism.
Methods: We assessed myocardial systolic and diastolic function and HEP metabolism in 12 asymptomatic normotensive male patients with recently diagnosed, well-controlled type 2 diabetes and 12 controls, using MR imaging and phosphorus-31-nuclear MR spectroscopy (31P-MRS) on a 1.5 T clinical scanner; 31P-MR spectra were quantified, and myocardial HEP metabolism was expressed as phosphocreatine to adenosine-triphosphate (PCr/ATP) ratio.
Results: No differences were found in LV mass and systolic function between patients and controls. However, early (E) acceleration peak, deceleration peak, peak filling rate, and transmitral early-to-late diastolic peak flow (E/A) ratio, all indexes of diastolic function, were significantly decreased in patients compared with controls (p < 0.02). In addition, myocardial PCr/ATP in patients was significantly lower than in controls (1.47 vs. 1.88, p < 0.01). Inverse associations were found between myocardial PCr/ATP and E acceleration peak, E deceleration peak, and E peak filling rate (all, p < 0.05).
Conclusions: These results indicate that altered myocardial energy metabolism may contribute to LV diastolic functional changes in patients with recently diagnosed, well-controlled and uncomplicated type 2 diabetes.
Similar articles
-
Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.J Am Coll Cardiol. 2009 Oct 13;54(16):1524-32. doi: 10.1016/j.jacc.2009.04.074. J Am Coll Cardiol. 2009. PMID: 19815124
-
Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.J Am Coll Cardiol. 2008 Nov 25;52(22):1793-9. doi: 10.1016/j.jacc.2008.07.062. J Am Coll Cardiol. 2008. PMID: 19022158
-
Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism.Circulation. 1999 May 4;99(17):2261-7. doi: 10.1161/01.cir.99.17.2261. Circulation. 1999. PMID: 10226091
-
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.Circulation. 2003 Jun 24;107(24):3040-6. doi: 10.1161/01.CIR.0000072789.89096.10. Epub 2003 Jun 16. Circulation. 2003. PMID: 12810608 Clinical Trial.
-
[Evaluation of left ventricular diastolic function using Doppler echocardiography].Med Pregl. 1999 Jan-Feb;52(1-2):13-8. Med Pregl. 1999. PMID: 10352498 Review. Croatian.
Cited by
-
Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids.Int J Mol Sci. 2020 Aug 22;21(17):6043. doi: 10.3390/ijms21176043. Int J Mol Sci. 2020. PMID: 32842567 Free PMC article. Review.
-
Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.Diabetes. 2015 Aug;64(8):2735-43. doi: 10.2337/db14-1560. Epub 2015 Mar 20. Diabetes. 2015. PMID: 25795215 Free PMC article.
-
A statistical model to identify hereditary and epigenetic fusion genes associated with dilated cardiomyopathy.Front Genet. 2024 Oct 1;15:1438887. doi: 10.3389/fgene.2024.1438887. eCollection 2024. Front Genet. 2024. PMID: 39411373 Free PMC article.
-
Molecular and cellular basis for diastolic dysfunction.Curr Heart Fail Rep. 2012 Dec;9(4):293-302. doi: 10.1007/s11897-012-0109-5. Curr Heart Fail Rep. 2012. PMID: 22926993 Review.
-
Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels.Pflugers Arch. 2012 Dec;464(6):613-21. doi: 10.1007/s00424-012-1165-0. Epub 2012 Oct 2. Pflugers Arch. 2012. PMID: 23053478
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical